Tue, March 1, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Mark Zgutowicz Initiated (SNAP) at Strong Buy and Held Target at $50 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Paul Fremont Initiated (CEG) at Hold and Held Target at $46 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Yanan Zhu Initiated (TSHA) at Buy and Held Target at $25 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Stanley Elliott Maintained (TREX) at Strong Buy with Decreased Target to $120 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Peter Benedict Maintained (TGT) at Buy and Held Target at $275 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Jamie Perse Initiated (THC) at Strong Buy on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Joshua Pokrzywinski Maintained (SWIM) at Hold with Decreased Target to $21 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Brian Essex Maintained (TASK) at Strong Buy with Decreased Target to $66 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Daniel Perlin Maintained (TASK) at Buy with Decreased Target to $46 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Nathan Rich Maintained (XRAY) at Hold with Decreased Target to $59 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Matt Miksic Maintained (XRAY) at Buy with Decreased Target to $67 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Mark Zgutowicz Initiated (TTD) at Hold on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Joshua Pokrzywinski Maintained (TT) at Buy with Decreased Target to $190 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Jason Cassorla Maintained (UHS) at Strong Buy with Increased Target to $167 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Taylor Zurcher Downgraded (WHD) to Hold on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Stephanie Yee Initiated (WM) at Hold and Held Target at $153 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Kunaal Malde Downgraded (WIX) to Hold and Held Target at $100 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Selman Akyol Maintained (WMB) at Strong Buy with Increased Target to $34 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Joshua Pokrzywinski Upgraded (WMS) to Buy and Held Target at $145 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Derrick Wood Maintained (WDAY) at Buy with Increased Target to $310 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Richard Nguyen Upgraded (WDAY) to Strong Buy on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Scott Berg Maintained (WDAY) at Strong Buy with Decreased Target to $300 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Michael Turrin Maintained (WDAY) at Buy with Increased Target to $340 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Brad Reback Maintained (WDAY) at Strong Buy with Decreased Target to $300 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Raimo Lenschow Maintained (WDAY) at Buy with Increased Target to $319 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Michael Turits Maintained (WDAY) at Buy with Decreased Target to $312 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Andrew Cooper Maintained (VCYT) at Buy with Decreased Target to $34 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Puneet Souda Maintained (VCYT) at Buy with Decreased Target to $40 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
John Barnidge Downgraded (VOYA) to Hold and Decreased Target to $74 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Naved Khan Downgraded (VRM) to Hold on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Zachary Fadem Downgraded (VRM) to Hold and Held Target at $480 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Jason Gerberry Downgraded (VTRS) to Hold and Decreased Target to $13 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Elliot Wilbur Downgraded (VTRS) to Hold on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Chris Pierce Initiated (ACVA) at Strong Buy and Held Target at $20 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Sami Badri Maintained (AMT) at Buy with Decreased Target to $300 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
John Barnidge Downgraded (AMP) to Hold and Decreased Target to $325 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Stephen Gengaro Maintained (AMRC) at Strong Buy with Decreased Target to $91 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Pavel Molchanov Maintained (AMRC) at Buy with Increased Target to $70 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Bradley Canino Maintained (ARVN) at Strong Buy with Decreased Target to $93 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Madhu Kumar Maintained (ARVN) at Strong Buy with Decreased Target to $110 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
John Abbott Maintained (ARCT) at Buy with Decreased Target to $107 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Timur Ivannikov Maintained (APLS) at Strong Buy with Increased Target to $114 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Parker Lane Maintained (BIGC) at Strong Buy with Decreased Target to $50 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Scott Berg Maintained (BIGC) at Strong Buy with Decreased Target to $40 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Gabriela Borges Maintained (BIGC) at Strong Buy with Decreased Target to $29 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Stan Zlotsky Maintained (BIGC) at Hold with Decreased Target to $26 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Josh Beck Maintained (BIGC) at Buy with Decreased Target to $30 on, Mar 1st, 2022
[ Tue, Mar 01st 2022 ]: WOPRAI
Peter Levine Maintained (ZM) at Hold with Decreased Target to $145 on, Mar 1st, 2022

John Abbott Maintained (ARCT) at Buy with Decreased Target to $107 on, Mar 1st, 2022

John Abbott of Wells Fargo, Maintained "Arcturus Therapeutics Holdings Inc." (ARCT) at Buy with Decreased Target from $118 to $107 on, Mar 1st, 2022.

John has made no other calls on ARCT in the last 4 months.



There are 2 other peers that have a rating on ARCT. Out of the 2 peers that are also analyzing ARCT, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Steven Seedhouse of "Raymond James" Upgraded from Sell to Hold on, Monday, January 31st, 2022


This is the rating of the analyst that currently disagrees with John

  • Gena Wang of "Barclays" Maintained at Sell with Decreased Target to $31 on, Tuesday, November 9th, 2021